North Carolina GlaxoSmithKline Foundation

Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study

Thomas Voit, Haluk Topaloğlu, Volker Straub et al. · The Lancet Neurology · 2014 · 295 citations

Medicine, Pharmacology, Pharmacotherapy +5

The Lifetime Cost of Bipolar Disorder in the US

Charles E. Begley, John F. Annegers, Alan C. Swann et al. · PharmacoEconomics · 2001 · 269 citations

Pharmacy, Pharmacoeconomics, Psychiatry +11

Prevalence of Severe (500 to 2,000 mg/dl) Hypertriglyceridemia in United States Adults

Jennifer Christian, Nancy Bourgeois, Rose Snipes et al. · The American Journal of Cardiology · 2011 · 156 citations · Full text

Medicine, Endocrinology, Internal Medicine +9

ING116070: A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in Cerebrospinal Fluid in HIV-1-Infected, Antiretroviral Therapy-Naive Subjects

Scott Letendre, Anthony Mills, Karen T. Tashima et al. · Clinical Infectious Diseases · 2014 · 136 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

PCA3 Molecular Urine Test for Predicting Repeat Prostate Biopsy Outcome in Populations at Risk: Validation in the Placebo Arm of the Dutasteride REDUCE Trial

Sheila M. J. Aubin, Jennifer Reid, Mark Sarno et al. · The Journal of Urology · 2010 · 132 citations

Medicine, Oncology, Urology +17